QIM
FOLD

Quantitative Investment Management’s Amicus Therapeutics FOLD Stock Holding History

Quantitative Investment Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-34,534
Closed -$329K – 321
2021
Q3 		$329K Buy
+34,534
New +$353K 0.03% 317
2021
Q2 		– Sell
-98,248
Closed -$970K – 466
2021
Q1 		$970K Buy
98,248
+82,682
+531% +$1.28M 0.08% 234
2020
Q4 		$359K Buy
+15,566
New +$318K 0.03% 379
2020
Q3 		– Sell
-63,849
Closed -$962K – 475
2020
Q2 		$962K Buy
+63,849
New +$778K 0.1% 218
2019
Q2 		– Sell
-41,400
Closed -$563K – 693
2019
Q1 		$563K Buy
+41,400
New +$506K 0.03% 481
2018
Q3 		– Sell
-132,400
Closed -$2.07M – 720
2018
Q2 		$2.07M Buy
132,400
+68,700
+108% +$1.04M 0.04% 357
2018
Q1 		$958K Sell
63,700
-88,300
-58% -$1.34M 0.02% 572
2017
Q4 		$2.19M Buy
+152,000
New +$2.09M 0.03% 490
2017
Q3 		– Sell
-194,400
Closed -$1.96M – 737
2017
Q2 		$1.96M Buy
+194,400
New +$1.56M 0.03% 503

Other funds holding FOLD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Quantitative Investment Management's FOLD Position: Q4 2021 in Review

Quantitative Investment Management sold out of Amicus Therapeutics (FOLD) in Q4 2021, closing a stake of 34,534 shares — an estimated $329K sold.

Quantitative Investment Management first reported a position in FOLD in Q2 2017 and held it in 9 quarters. The position peaked at $2.19M in Q4 2017. 224 funds tracked by Wall St. Rank hold FOLD as of Q4 2021.

  • Quantitative Investment Management reported no remaining Amicus Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Quantitative Investment Management sold 34,534 Amicus Therapeutics shares in Q4 2021, an estimated $329K.
  • Quantitative Investment Management first reported a position in Amicus Therapeutics in Q2 2017 and held it in 9 quarters.
  • Quantitative Investment Management's Amicus Therapeutics position peaked at $2.19M in Q4 2017.
  • 224 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2021.

Based on Quantitative Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.